Abstract
In a double blind randomised controlled trial, 30 infants with chronic lung disease received fluticasone propionate or placebo for one year. There were no significant differences between treatment groups in the incidence of any day or night time symptoms or any other outcome measures.
| Original language | English |
|---|---|
| Pages (from-to) | F62-F63 |
| Journal | Archives of Disease in Childhood - Fetal and Neonatal Edition |
| Volume | 87 |
| Issue number | 1 |
| DOIs | |
| Publication status | Published - 2002 |
Fingerprint
Dive into the research topics of 'Randomised double blind placebo controlled trial of inhaled fluticasone propionate in infants with chronic lung disease'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver